ATOSSA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Atossa Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Atossa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $749K, a 19.1% decline year-over-year.
  • Atossa Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.04M, a 63.9% decline year-over-year.
  • Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.62M, a 31.9% decline from 2022.
  • Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.79M, a 28.9% increase from 2021.
  • Atossa Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.27M, a 74.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.62M -$2.17M -31.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $6.79M +$1.52M +28.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $5.27M +$2.25M +74.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $3.02M -$4.08M -57.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $7.1M +$6.05M +574% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $1.05M +$267K +33.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $787K -$89.6K -10.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 $876K +$36.1K +4.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $840K +$284K +51% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-03-21
2014 $556K -$887K -61.5% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $1.44M $0 0% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 $1.44M Jan 1, 2012 Dec 31, 2012 10-K 2014-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.